Nuream
PrivateLast Round
Grant
May 21, 2026
Total Funding Raised
$1.84M
Company Overview
Nuream is a neurodata science company that develops fabric-as-a-sensor technology to monitor brain activity and sleep patterns for health insights and disease detection.
Sector
AI, Data & Cloud Infrastructure
Verticals
Biotechnology
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuream Comparables
Compare Nuream with similar companies based on industry and business-model similarity.
No public comparables are available for Nuream. Request access to learn about comparables coverage.
Request accessNuream Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 21, 2026 | ||||
| Grant | May 21, 2026 | ||||
| Grant | Apr 8, 2025 | ||||
| Pre Seed | Jan 22, 2025 |
Nuream Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NC IDEA | Grant |
| NCInnovation | Grant |
Nuream Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nuream's valuation, stock price, and market status.
Is Nuream a public or private company?
Nuream is a private company.
What is the current stock price of Nuream?
Nuream is a private company, so its shares have no public market price. Caplight tracks Nuream's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nuream worth (valuation)?
Valuation information for Nuream is not publicly available.
Can I buy Nuream stock?
Nuream shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nuream's last funding round?
Nuream's most recent funding round was Grant on May 21, 2026.
Who are the main investors in Nuream?
Key investors in Nuream include NC IDEA, NCInnovation.
Will Nuream IPO soon?
No public IPO plans have been announced for Nuream.
How can I track Nuream secondary market activity?
Caplight tracks bids, offers, and trades in Nuream's shares on secondary markets.